维普期刊资源整合服务平台（V6.5）

75篇 您的检索式：作者名="Chappell WH"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Inhibition of GSK-3~3 activity can result in drug and hormonal re- sistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cells 显示文摘	Sokolosky M Chappell WH Stadelman K	2014	Cell Cycle2014，13，5：	1
2	Roles of the Raf/MEK/ERKpathway in cell growth,malignant transformation and drug resistance显示文摘	McCubrey JA Steelman LS Chappell WH		0，，08：	1
3	Akt as a therapeutic target in cancer显示文摘	Steelman LS Stadelman KM Chappell WH		0，，09：	1
4	Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors:rationale and importance to inhibiting these pathways in human health显示文摘	Chappell WH Steelman LS Long JM		0，，03：	1
5	Role of the Raf/MEK/ ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging显示文摘	Steelman LS Chappell WH Abrams SL	2011	Aging (Albany NY)2011，3，3：	1
6	Roles of the Raf/MEK /ERK pathway in cell growth,malignant transformation and drug resistance显示文摘	McCubrey JA Steelman LS Chappell WH	2007	Biochim Biophys Acta2007，1773，8：	1
7	Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance显示文摘	McCubrey JA Steelman LS Chappell WH	2007	Biochim Biophys Acta2007，1773，8：	1
8	'targeting the cancer initiating cell:the Achilles' heel of cancer 显示文摘	Mccubrey J A Chappell WH Abrams SL	2011	Adv Enzyme Regul2011，51，1：	1
9	Roles of the Raf/MEK/ ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy- implications for cancer and aging 显示文摘	Steelman IS Chappell WH Abram SL	2011	Aging2011，3，3：	1
10	Roles of the Raf/MEK pathway in cell growth,malignant,transformation and drug resistance显示文摘	Mc Cubrey JA Steelman LS Chappell WH	2007	Biochim Biophys Acta2007，1773，8：	1
11	Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/m TOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging显示文摘	Steelman LS Chappell WH Abrams SL	2011	Aging(Albany NY)2011，3，3：	1
12	Cooperative effects of Akt-1 and Raf-1 on the induction of cellular senescence in doxombicin or tamoxifen treated breast cancer cells显示文摘	Taylor JR Lehmann BD Chappell WH		0，，08：	1
13	Inhibition of GSK-313 activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cells 显示文摘	Sokolosky M Chappell WH Stadelman K	2014	Cell Cycle2014，13，5：	1
14	Roles of the Raf/ MEK/ERK pathway in cell growth, malignant transformation and drug resistance显示文摘	McCubrey JA Steelman LS Chappell WH	2007	Biochim Biophys Acta2007，1773，8：	1
15	Roles of the Raf/MEK/ERK pathway in cell growth,malignant transformation and drug resistance显示文摘	McCubrey JA Steelman LS Chappell WH	2007	Biochim Biophys Acta2007，1773，8：	1
16	Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging 显示文摘	Steelman LS Chappell WH Abrams SL	2011	Aging (Albany NY)2011，3，3：	1
17	Roles of the Raf/MEK/ERK pathway in cell growth,malignant,transformation and drug resistance显示文摘	McCubrey JA Steelman LS Chappell WH		0，，08：	1
18	Ras/Raf/ MEK/ERK and PI3K/PTEN/Akt/mTOR cascade in- hibitors:how mutations can result in therapy resistance and how to overcome resistance显示文摘	McCubrey JA Steelman LS Chappell WH	2012	Oncotarget2012，3，10：	1
19	Akt as a therapeutic target in cancer 显示文摘	Steelman LS Stadelman KM Chappell WH	2008	Expert Opin Ther Targets2008，12，9：	1
20	Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response 显示文摘	MeCubrey JA Steelman LS Chappell WH	2012	Oncotarget2012，3，9：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示